Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity
Cell Metabolism · 2024-05 · 36 (5) · 1013-1029.e5
DOI: 10.1016/j.cmet.2024.03.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2024-05. Verfasst von Lingfeng Tong und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Key Laboratory of Cell Di…. Hauptthemen laut MEDLINE: Inosine, Mitochondria, Transketolase. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, School of Medicine, Shanghai Jiao Tong University.
Abstract (Originalsprache)
Metabolic dysfunction-associated fatty liver disease (MAFLD) has a global prevalence of about 25% and no approved therapy. Using metabolomic and proteomic analyses, we identified high expression of hepatic transketolase (TKT), a metabolic enzyme of the pentose phosphate pathway, in human and mouse MAFLD. Hyperinsulinemia promoted TKT expression through the insulin receptor-CCAAT/enhancer-binding protein alpha axis. Utilizing liver-specific TKT overexpression and knockout mouse models, we demonstrated that TKT was sufficient and required for MAFLD progression. Further metabolic flux analysis revealed that Tkt deletion increased hepatic inosine levels to activate the protein kinase A-cAMP response element binding protein cascade, promote phosphatidylcholine synthesis, and improve mitochondrial function. Moreover, insulin induced hepatic TKT to limit inosine-dependent mitochondrial activity. Importantly, N-acetylgalactosamine (GalNAc)-siRNA conjugates targeting hepatic TKT showed promising therapeutic effects on mouse MAFLD. Our study uncovers how hyperinsulinemia regulates TKT-orchestrated inosine metabolism and mitochondrial function and provides a novel therapeutic strategy for MAFLD prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai…
- Unit of Immune and Metabolic Regulation, School of Life Science and Technology, Shanghai Tech University, Shanghai 201210, China.
- Department of Liver Surgery, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
- Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shanghai Medical College of Fudan University, Shangha…
- Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.
- Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- School of Medicine, Shanghai Jiao Tong University
- Innovative Research Team of High-level Local University in Shanghai
Zitieren
APA
Tong, L., Chen, Z., Li, Y., Wang, X., Yang, C., Li, Y., Zhu, Y., Lu, Y., Liu, Q., Xu, N., Shao, S., Wu, L., Zhang, P., Wu, G., Wu, X., Chen, X., Fang, J., Jia, R., Xu, T., …, & Tong, X. (2024). Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. Cell Metabolism, 36(5), 1013-1029.e5. https://doi.org/10.1016/j.cmet.2024.03.003
Vancouver
Tong L, Chen Z, Li Y, Wang X, Yang C, Li Y, et al. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. Cell Metabolism. 2024;36(5):1013-1029.e5. doi:10.1016/j.cmet.2024.03.003
BibTeX
@article{Tong2024,
author = {Tong, Lingfeng and Chen, Zhangbing and Li, Yangyang and Wang, Xinxia and Yang, Changjie and Li, Yakui and Zhu, Yemin and Lu, Ying and Liu, Qi and Xu, Nannan and Shao, Sijia and Wu, Lifang and Zhang, Ping and Wu, Guangyu and Wu, Xiaoyu and Chen, Xiaosong and Fang, Junwei and Jia, Renbing and Xu, Tianle and Li, Bin and Zheng, Liang and Liu, Junling and Tong, Xuemei},
title = {Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity},
journal = {Cell Metabolism},
year = {2024},
volume = {36},
number = {5},
pages = {1013--1029.e5},
doi = {10.1016/j.cmet.2024.03.003}
}
EUVIMED